{
    "clinical_study": {
        "@rank": "73993", 
        "arm_group": [
            {
                "arm_group_label": "QD combination group", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "BID combination group", 
                "arm_group_type": "Active Comparator"
            }, 
            {
                "arm_group_label": "SYR-322 alone group", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "To evaluate the safety and efficacy of treatment with metformin hydrochloride in diabetic\n      patients when used in combination with SYR-322."
        }, 
        "brief_title": "Double-blind Comparative Study of SYR-322-MET.", 
        "completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Diabetes", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patient who is an outpatient during the observation period.\n\n          -  Patient who signs and dates a written, informed consent form and any required privacy\n             authorization prior to the initiation of any study procedures.\n\n        Exclusion Criteria:\n\n          -  Patient who has any serious cardiac disease, serious cerebrovascular disorder, or any\n             serious pancreatic or hematological disease.\uff08e.g., subjects who require\n             hospitalization or subjects who were hospitalized within 24 weeks prior to the\n             commencement of the observation period)\n\n          -  Patient who is considered ineligible for the study for any other reason by the\n             investigator or subinvestigator."
            }, 
            "gender": "Both", 
            "maximum_age": "74 Years", 
            "minimum_age": "20 Months"
        }, 
        "enrollment": {
            "#text": "385", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 19, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02068443", 
            "org_study_id": "SYR-322-MET/CCT-001", 
            "secondary_id": [
                "JapicCTI-132377", 
                "U1111-1151-6515"
            ]
        }, 
        "intervention": [
            {
                "arm_group_label": "QD combination group", 
                "intervention_name": "SYR-322 + metformin hydrochloride", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "BID combination group", 
                "intervention_name": "SYR-322 + metformin hydrochloride", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "SYR-322 alone group", 
                "intervention_name": "SYR-322 + metformin hydrochloride placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Alogliptin", 
                "Metformin"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 19, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Sendai-shi", 
                    "country": "Japan", 
                    "state": "Miyagi"
                }
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Japan"
        }, 
        "number_of_arms": "3", 
        "official_title": "Double-blind Comparative Study When Metformin Hydrochloride is Added on to SYR-322.", 
        "overall_contact": {
            "email": "medicalinformation@tpna.com", 
            "last_name": "Takeda Study Registration Call Center", 
            "phone": "+1-800-778-2860"
        }, 
        "overall_official": {
            "affiliation": "Takeda", 
            "last_name": "Study Director", 
            "role": "Study Director"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Japan: Ministry of Health, Labor and Welfare"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Measurement of change from baseline in HbA1c", 
            "measure": "HbA1c", 
            "safety_issue": "No", 
            "time_frame": "Baseline and Week 24"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02068443"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Measurement of HbA1c and fasting blood glucose", 
                "measure": "HbA1c and fasting blood glucose", 
                "safety_issue": "No", 
                "time_frame": "Baseline and Week 24"
            }, 
            {
                "description": "Number of cases with adverse events", 
                "measure": "Adverse events", 
                "safety_issue": "No", 
                "time_frame": "Baseline and Week 24"
            }
        ], 
        "source": "Takeda", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Takeda", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}